Order results by:
| Issue | Title | |
| Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
| M. V. Solodun, S. S. Yakushin | ||
| "... Aim. To analyze the impact of the SLCO1B1*5 (c.521T> C) and LIPC (C514T) genes polymorphisms ..." | ||
| Vol 4, No 2 (2008) | EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY | Abstract similar documents |
| A. V. Semenov, D. A. Sichev, V. G. Kukes | ||
| "... Aim. To study effects of genes SLCO1B1 and MDR1 polymorphism on atorvastatin pharmacokinetics ..." | ||
| Vol 7, No 2 (2011) | LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE | Abstract similar documents |
| A. V. Susekov, N. V. Khokhlova | ||
| "... of atorvastatin is demonstrated in according to comparative studies. Results of clinical studies on atorvastatin ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
| A. N. Meshkov | ||
| "... is - the lower risk of cardiovascular diseases and their complications are. Efficacy and safety of atorvastatin ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| Vol 9, No 6 (2013) | APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY | Abstract similar documents |
| D. A. Sychev, G. N. Shuev, A. B. Prokofiev | ||
| "... The clinical significance of the SLCO1B1 gene polymorphism (encoding an organic anion transport ..." | ||
| Vol 10, No 4 (2014) | STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN | Abstract similar documents |
| N. G. Gogolashvili | ||
| "... The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction ..." | ||
| Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
| O. M. Drapkina, A. S. Lishuta | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... Aim. To study the effect of atorvastatin on the rate of atrial fibrillation (AF) recurrence after ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..." | ||
| Vol 9, No 3 (2013) | INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina | ||
| "... into the study. Total plasma creatine kinase levels were measured and SLCO1B1*5 genotyping was performed ..." | ||
| Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
| A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
| "... Aim. To assess the safety of the application of high-dose atorvastatin and its effect on metabolic ..." | ||
| Vol 6, No 4 (2010) | RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE | Abstract similar documents |
| M. V. Ezhov | ||
| "... The results of the recently completed clinical studies on the efficacy of atorvastatin in high ..." | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... ) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods. 60 patients with IHD ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
| G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
| "... antihypertensive and glucose-lowering therapy. Patients of group 1 were additionally receiving atorvastatin 20 mg ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| Vol 11, No 5 (2015) | Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease | Abstract similar documents |
| O. A. Rubanenko | ||
| "... Aim. To evaluate the efficacy of atorvastatin therapy in prevention of atrial fibrillation (AF ..." | ||
| Vol 1, No 3 (2005) | PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE | Abstract similar documents |
| V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova | ||
| "... with initial dislipidemia were prescribed lipid reducing drug atorvastatin in 10mg daily dose additionally ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... Aim. To study the effectiveness of atorvastatin 80 mg, prescribed immediately prior emergency ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... of therapy with atorvastatin in different doses in patients with acute ST-segment elevation myocardial ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... .5%, whereas prescription of atorvastatin and rosuvastatin increased from 31.4% to 64.5% and from 3.6% to 9 ..." | ||
| Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
| "... visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... high (269, 90.3%) CVR. All patients were recommended to take the reproduced drugs of atorvastatin ..." | ||
| Vol 2, No 2 (2006) | METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS | Abstract similar documents |
| N. V. Perova, I. N. Ozerova, V. A. Metelskaya | ||
| Vol 15, No 3 (2019) | Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population | Abstract similar documents |
| K. B. Mirzaev, D. S. Fedorinov, D. V. Ivashchenko, D. A. Sychev | ||
| "... », «CYP4F2», «CYP4F1», «ABCB1», «SLCO1B1», «VKORC1», «GGCX», «SULT1A1», «CULT1», «CES1», «gene», «genes ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... Aim. To study the effect of atorvastatin on the progression of the arrhythmia in hypertensive ..." | ||
| Vol 13, No 3 (2017) | PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION | Abstract similar documents |
| A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko | ||
| "... rs1045642 and SLCO1B1 gene rs4149056 polymorphisms have no effect on edoxaban pharmacokinetics ..." | ||
| Vol 10, No 2 (2014) | PREVALENCE RATE OF PSYCHOGENIC RISK FACTORS AMONG PATIENTS WITH ARTERIAL HYPERTENSION OF VARIOUS DEGREES ACCORDING TO CRITERIA OF EVIDENCE-BASED MEDICINE | Abstract similar documents |
| B. B. Fishman, I. N. Kochanov, A. I. Horoshevskaja, M. A. Bobyr, D. A. Shamiladze, L. A. Fomenko, V. V. Kostirkina, Yu. O. Yevstyukhina | ||
| "... by logistical regress model using disagreement criterion (odds ratio). Results. HT prevalence rate was 52.1 ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... .32% of patients, enalapril 20 mg/day – 30.45%, simvastatin and atorvastatin 20 mg/day – 64.52% and 47 ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... treatment with atorvastatin for the primary prevention of cardiovascular complications in patients ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... up to 8.3%. When choosing among statins specialists recommended significantly more often atorvastatin ..." | ||
| Vol 12, No 2 (2016) | CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, M. A. Efremovtseva | ||
| "... developed in 121 (43.5%) patients, and in 52.9% of cases was nosocomial, in 53.7% transient and in 52.1 ..." | ||
| Vol 8, No 2 (2012) | UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev | ||
| "... , at that 259 (50%) in hospital and 260 (50%) - in out-patient clinic. 521 patients took DAT according ..." | ||
| Vol 14, No 4 (2018) | Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee | ||
| "... to hospitalization, 34.6% were obese and 52.1% had a high cholesterol level. Only 40.0% of patients had no contact ..." | ||
| Vol 4, No 3 (2008) | THE RUSSIAN DATA OF INTERNATIONAL ENDORSE REGISTER (EPIDEMIOLOGIC INTERNATIONAL DAY FOR THE EVALUATION OF PATIENTS AT RISK OF VENOUS THROMBOSIS IN ACUTE HOSPITAL CARE SETTING) | Abstract similar documents |
| V. A. Sulimov, S. M. Belentsov, N. I. Golovina, N. P. Dubrovnaja, K. P. Zhidkov, K. V. Yeliseyeva, P. O. Kazanchan, A. V. Redkin, G. V. Rodoman, I. L. Fridman, V. N. Shershnev | ||
| "... risks received VTE preventive therapy according to АССР Recommendations 2004. In Russia 521 (23 ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
| "... with simvastatin, in 75.2% of the patients treated with atorvastatin, in 59% of the patients treated ..." | ||
| Vol 10, No 6 (2014) | DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) | Abstract similar documents |
| A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov | ||
| "... atorvastatin 40 mg per day. Blood LDC levels were examined only in 5% of patients during statins therapy ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... . Atorvastatin (Tulip, LEK) 20-40 mg OD was prescribed for HH control. Management of CG patients was performed ..." | ||
| Vol 7, No 6 (2011) | COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... the lowest cost of BP reduction (12.33 rubles/mm Hg) and correction of MAU prevalence rate (1 514 rubles/case ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... predictor for obtaining good INR control (odds ratio=133, 95% confidence interval 34.24-514.44, p<0 ..." | ||
| Vol 1, No 3 (2005) | CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL | Abstract similar documents |
| M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina | ||
| "... ,97% and 5,14%, respectively. Local contractility index decreased significantly only in carvedilol group ..." | ||
| Vol 16, No 6 (2020) | What factors are Associated with the Development of Contras-induced Nephropathy in Elderly Patients with Acute Coronary Syndrome in Real Clinical Practice? | Abstract similar documents |
| M. Yu. Gilyarov, E. V. Konstantinova, P. V. Kovalets, A. V. Slivin, A. E. Udovichenko, A. P. Nesterov, O. N. Svetlova, A. V. Svet | ||
| "... with acute coronary syndrome (ACS). Material and Methods. A retrospective analysis of 514 electronic medical ..." | ||
| Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
| E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
| "... in 26 (83.9%) of 31 patients receiving DOAC and in 19 (51.4%) of 37 patients receiving warfarin (p=0 ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... with atorvastatin 80 mg/day. The results were considered statistically significant at p<0.05. Results. 16 (27 ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... atorvastatin (10-80 mg/day) or rosuvastatin (10-40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
| Vol 14, No 2 (2018) | HYPERTENSION AND DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... , hypolipidemic therapy with atorvastatin 17.0Ѓ}4.7 mg/day and combined hypoglycemic therapy with metformin 1093 ..." | ||
| Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
| S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
| "... atorvastatin (10-80 mg/day) or rosuvastatin (10- 40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... .2-5.3 (p<0.001). Doctors preferred atorvastatin in prescriptions (n=456, 55.4%), rosuvastatin (n=244 ..." | ||
| Vol 17, No 4 (2021) | Association of SCN5A gene polymorphism with dilated cardiomyopathy | Abstract similar documents |
| S. Yu. Nikulina, O. O. Kuznetsova, A. A. Chernova, G. V. Matyushin, A. A. Gurazheva, V. N. Maksimov | ||
| "... 1805124). Results. In the group with IDC 51.4% of patients were carriers of the common homozygous AA ..." | ||
| Vol 18, No 3 (2022) | Association of Heart Rate Variability with the Psychosocial Stress Level in Men 41-44 Years Old Living in Moscow | Abstract similar documents |
| O. M. Drapkina, V. B. Rozanov, A. V. Kontsevaya, O. Yu. Isaykina, G. A. Muromtseva, M. B. Kotova, E. S. Akarachkova | ||
| "... (36.7-62.3), p=0.030; and 46.7 (44.7-48.6) versus 49.7 (48.1-51.4), p=0.019; respectively ..." | ||
| Vol 13, No 2 (2017) | ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC | Abstract PDF (Eng) similar documents |
| E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov | ||
| "... .6), CHA2DS2-VASc and HAS-BLED score were estimated as 5.14Ѓ}1.50 и 1.59Ѓ}0.79, respectively ..." | ||
| Vol 16, No 1 (2020) | An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results | Abstract similar documents |
| S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy | ||
| "... .9% of patients had a history of acute myocardial infarction (AMI), 52.1% had percutaneous coronary intervention ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..." | ||
| Vol 16, No 5 (2020) | Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes | Abstract similar documents |
| A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina | ||
| "... , 41.5%) and 481 patients (247 men, 51.4%). Clinical and anamnestic characteristics, risk factors ..." | ||
| Vol 17, No 1 (2021) | Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease | Abstract similar documents |
| S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova | ||
| "... , males 51.4%) with established stable coronary artery disease (SCAD) were included. Demography, medical ..." | ||
| 1 - 57 of 57 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
